Clinical Trials Sponsored by New York Prostate Institute

Total 942 results

New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

Hormone Release and Stomach Disturbances in People With Binge Eating Disorder

Obesity | Eating Disorders | Binge Eating Disorder

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Terminated

Cholecystokinin for Reducing Binge Eating in People With Bulimia Nervosa

Bulimia Nervosa | Eating Disorders

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Opiate Dependence: Combined Naltrexone/Behavior Therapy - 1

Heroin Dependence

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

Group Interpersonal Psychotherapy for Depressed Adolescents in School-based Clinics

Depression
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Withdrawn

Multimodal Assessment of Cannabinoid Target Engagement in Adults With Obsessive-Compulsive Disorder

Obsessive-Compulsive Disorder

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Suspended

Extended-Release Buprenorphine vs. Sublingual Buprenorphine for the Treatment of Opioid Use Disorder

Opioid-use Disorder

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Active, not recruiting

Facilitating Rapid Naltrexone Initiation

Opioid Dependence

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

Effectiveness of High Intensity Inpatient Versus Stepped Intensity Treatment for Anorexia Nervosa

Eating Disorders

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Active, not recruiting

Glutamatergic Mechanisms of Psychosis and Target Engagement (SA1)

Healthy

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

A Strategy to Improve Success of Treatment Discontinuation in Buprenorphine Responders

Opioid-use Disorder

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

Improving Accessibility and Personalization of CR for Schizophrenia

Schizophrenia | Schizoaffective Disorder

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

Glutamate Reducing Interventions in Schizophrenia

Clinical High Risk for Psychosis

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Treatment Outcome in CBT for Cocaine Use

Cocaine Use Disorder

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

Effects of Adding Motivational Interviewing to Antidepressant Treatment for Hispanic Adults With Depression

Depression

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

Antidepressant Response in the Treatment of Depressive Symptoms and Frailty Characteristics in Older Adults

Major Depressive Disorder | Dysthymic Disorder | Depressive Disorder, NOS

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Terminated

Lorcaserin for Cannabis Use Disorder

Cannabis Use Disorder

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

Treatment of Attention Deficit Hyperactivity Disorder in Preschool-Age Children (PATS)

Attention Deficit Disorder With Hyperactivity

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

Personalized and Scalable Cognitive Remediation Approaches

Schizophrenia | Schizoaffective Disorder

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Withdrawn

NT-814: Evaluation of Its Ability to Alter the Abuse Liability of Oxycodone in an Exploratory Clinical Study (NT-814)

Opioid Use Disorder

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

Treatment of Adolescent Suicide Attempters (TASA)

Depression | Suicide, Attempted

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

Ketamine in the Treatment of Suicidal Depression

Suicidal Ideation | Major Depressive Disorder

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine/Naloxone Stabilization and Induction Onto Injection Naltrexone

Opioid Dependence

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

Effectiveness of Olanzapine Versus Placebo in Treating Outpatients With Anorexia Nervosa

Eating Disorders

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Study of Adderall-XR for the Treatment of Adult Attention Deficit Hyperactivity Disorder and Cocaine Dependence (CAMP)

Cocaine Dependence | Adult Attention Deficit Hyperactivity Disorder

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Study of Quetiapine Treatment for Cannabis Dependence (STUC)

Cannabis Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Free Venlafaxine Treatment for Marijuana Addiction and Depression - 1 (VEN)

Depression | Marijuana Abuse

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Atomoxetine for Treating Cocaine Abuse in Adults With Attention Deficit Hyperactivity Disorder (ADHD) (Atom)

Cocaine-Related Disorders | Attention Deficit Disorder With Hyperactivity

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Study of Buprenorphine Maintenance Treatment for Opioid Dependence in Primary Care

Substance Abuse, Intravenous | Opioid-Related Disorders | Heroin Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Methylphenidate Treatment for Cocaine Abuse and ADHD - 1

Cocaine-Related Disorders | Attention Deficit Disorder With Hyperactivity

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

Biomarker Assessment of Glutamatergic Target Engagement

Healthy Controls

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Memantine as a Supplement to Naltrexone in Treating Heroin Dependence (NAMHS)

Heroin Dependence | Opioid Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Effects of Varenicline on Cigarette Self Administration

Nicotine Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Memantine and Naltrexone Treatment for Opioid Dependence (NAMHS-1)

Opioid Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Nalrexone Facilitated Discontinuation of Buprenorphine

Stable Opioid Dependence

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

Fluoxetine to Prevent Relapse and Enhance Psychological Recovery in Women With Anorexia Nervosa

Anorexia Nervosa | Eating Disorders

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

Paroxetine/Bupropion in Depression With Suicide Attempt or Thoughts: fMRI Study

Depression | Suicidal Ideation

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Mirtazapine for Treating Cocaine Dependent Individuals Who Also Suffer From Depression

Depression | Cocaine Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Behavioral Naltrexone Therapy for Promoting Adherence to Oral Naltrexone vs Extended Release Injectable Depot Naltrexone (Depot-BNT)

Heroin Dependence | Opiate Dependence

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

Comparing Treatments for Self-Injury and Suicidal Behavior in People With Borderline Personality Disorder

Suicide | Borderline Personality Disorder

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Web-delivery of Evidence-based, Psychosocial Treatment for Substance Use Disorders (CTN-0044)

Substance Abuse

United States
National Institute on Drug Abuse (NIDA)
New York State Psychiatric Institute

Completed

Pergolide Treatment for Substance Abusers - 4

Substance-Related Disorders | Cocaine-Related Disorders

United States
New York State Psychiatric Institute

Completed

Women's Treatment for Trauma and Substance Use Disorders - 1

Substance-Related Disorders

United States
New York State Psychiatric Institute

Completed

HIV/STD Safer Sex Skills Groups for Women in Drug Treatment Programs - 1

Behavior Therapy

United States
National Institute on Drug Abuse (NIDA)
New York State Psychiatric Institute

Completed

Flupenthixol and Haloperidol for Treating Cocaine Abuse Schizophrenics - 9

Substance-Related Disorders | Cocaine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
New York State Psychiatric Institute

Completed

Flupenthixol Treatment in Schizophrenic Cocaine Abusers - 1

Cocaine-Related Disorders

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

Characteristics and Importance of Physical Activity in Women With Anorexia Nervosa

Eating Disorders

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

Changes in Dopamine Levels Before and After Weight Restoration in People With Anorexia Nervosa

Eating Disorders

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

Comparing the Effects of Four Types of Electroconvulsive Therapy on Mood and Thinking in People With Depression

Depression

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

The Influence of Aerobic Exercise on Cognitive Functioning in Schizophrenia.

Schizophrenia

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

Effectiveness of Armodafinil for Treating Fatigue in Adults With HIV/AIDS

HIV Infections | Fatigue

United States

Clinical Trials Sponsored by New York Prostate Institute

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cambodia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations